inPROBE Overview
inPROBE® diagnostic technology
- First photonic real-time immunoassay system, utilizing molecular biology, chemistry, and biomedical engineering
- Real-time detection of HER2 biomarker and potentionally also other proteins, antibodies and peptides, including other cancer biomarkers
- Potential point-of-care diagnostic aid to support and reduce the time to diagnosis
- Novel analyzer with photonic sensor probe consisting of 4 microprobes for biomarker detection in tissue and liquid samples
- Each microprobe tip covered with monoclonal antibodies (mAbs) for HER2 or other chosen target detection
How inPPROBE works in HER2 biomarker detection in breast cancer
inPPROBE is a new diagnostic technology combining photonics with molecular biology to detect HER2 expression in breast cancer. This point-of-care solution offers the potential to complement immunohistochemistry (IHC) and in situ hybridization (ISH) assays, addressing HER2 heterogeneity to improve access to targeted therapies such as trastuzumab and novel ADCs.
We Care About Your Privacy
SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.